Progressive multifocal leukoencephalopathy and natalizumab - Unforeseen consequences

被引:192
|
作者
Berger, JR [1 ]
Koralnik, IJ
机构
[1] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA
[2] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA
[3] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 04期
关键词
D O I
10.1056/NEJMe058122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:414 / 416
页数:3
相关论文
共 50 条
  • [31] Predictors of survival in natalizumab-associated progressive multifocal leukoencephalopathy
    Dong-Si, T.
    Gangadharan, A.
    Gheuens, S.
    Wenten, M.
    Philip, J.
    McIninch, J.
    Datta, S.
    Richert, N.
    Bozic, C.
    Bloomgren, G.
    Richman, S.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 155 - 155
  • [32] New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab
    Hartung, Hans-Peter
    LANCET NEUROLOGY, 2009, 8 (01): : 28 - 31
  • [33] Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen
    Hervas-Garcia, Jose Vicente
    Presas-Rodriguez, Silvia
    Crespo-Cuevas, Ane Miren
    Canento, Tamara
    Lozano-Sanchez, Manuel
    Massuet-Vilamajo, Anna
    Ramo-Tello, Cristina
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (05) : 399 - 402
  • [34] Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment
    Fabis-Pedrini, Marzena J.
    Xu, Wen
    Burton, Jason
    Carroll, William M.
    Kermode, Allan G.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 25 : 145 - 147
  • [35] Progressive multifocal leukoencephalopathy after natalizumab discontinuation: Few and true?
    Wattjes, Mike P.
    Killestein, Joep
    ANNALS OF NEUROLOGY, 2014, 75 (03) : 462 - 462
  • [36] Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
    Vermersch, P.
    Kappos, L.
    Gold, R.
    Foley, J. F.
    Olsson, T.
    Cadavid, D.
    Bozic, C.
    Richman, S.
    NEUROLOGY, 2011, 76 (20) : 1697 - 1704
  • [37] Progressive multifocal leukoencephalopathy and multiple sclerosis: Lessons from natalizumab
    Annette Langer-Gould
    Lawrence Steinman
    Current Neurology and Neuroscience Reports, 2006, 6 : 253 - 258
  • [38] Progressive multifocal leukoencephalopathy and multiple sclerosis: Lessons from natalizumab
    Langer-Gould, Annette
    Steinman, Lawrence
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2006, 6 (03) : 253 - 258
  • [39] Etiopathogenesis and diagnostics of progressive multifocal leukoencephalopathy in patients treated with natalizumab
    Stourac, P.
    Bednarova, J.
    Pavelek, Z.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2021, 84 (02) : 135 - 138
  • [40] Progressive multifocal leukoencephalopathy during natalizumab treatment: a ase report
    Moiola, L.
    Sangalli, F.
    Radaelli, M.
    Barcella, V.
    Gerevini, S.
    Cinque, P.
    Martinelli, V.
    Comi, G.
    JOURNAL OF NEUROLOGY, 2010, 257 : S145 - S145